Delivery Order SPE2DB22D2206-SPE2DB25FKA05
- Not listed
- The Defense Logistics Agency awarded a $1,630.47 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses, an antibiotic pharmaceutical product. The contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 1 GM Add-Van vials valued at $1,141.16, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,475.52 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50mL-Dextrose on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside contract was awarded under firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's significantly larger Indefinite...
- The Defense Logistics Agency awarded a $2,047.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous formulation. This non-set-aside competitive award is set for ultimate completion by August 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solutions, with an ultimate completion date of October 29, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,638.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with dextroses, with a completion date of September 8, 2025. The award was made on September 5, 2025, and is non-set-aside, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,904.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 1GM 25S, an antibiotic pharmaceutical product. The contract was competitively awarded without a set-aside designation and has an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $2,754.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose solution on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-compete, non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA05Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 GM vials under a firm fixed-price contract. The award, issued on September 19, 2025, has a ceiling value of $1,819.39 with an ultimate completion date of September 22, 2025. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, was selected through open competition without set-aside designations. The company serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products to support military and veteran healthcare systems. This specific delivery order for the antibiotic Cefazolin aligns with the contractor's broader portfolio of medical commodities delivered through the DLA Pharmaceutical Prime Vendor program, which enables the company to supply medications and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/19/25 |